* Hemispherx Biopharma Inc says on June 2, obtained omnibus
assignment of all intellectual property rights of former CEO
William Carter
The post BRIEF-Hemispherx Biopharma says obtained omnibus assignment of all IP rights of ex-CEO Carter appeared first on NASDAQ.